Jacquie Ross | VP, IR |
Daniel O'Day | Chairman & CEO |
Johanna Mercier | Chief Commercial Officer |
Merdad Parsey | Chief Medical Officer |
Andrew Dickinson | EVP & CFO |
Christi Shaw | CEO, Kite |
Brian Abrahams | RBC Capital Markets |
Geoffrey Meacham | Bank of America |
Tyler Van Buren | Cowen and Company |
Olivia Brayer | Cantor Fitzgerald |
Umer Raffat | Evercore ISI |
Matthew Harrison | Morgan Stanley |
David Risinger | SVB Securities |
Salveen Richter | Goldman Sachs |
Michael Yee | Jefferies |
Steven Seedhouse | Raymond James |
Carter Gould | Barclays |
Mohit Bansal | Wells Fargo |
Good day and thank you for standing by. Welcome to Gilead Sciences Second Quarter 2022 Earnings Conference Call. All lines have been placed on mute to prevent background noises. After today’s remarks, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's call is being recorded.